Share
The San Diego Union-Tribune
Sorrento Therapeutics of San Diego said Friday that an antibody it has been developing proved highly effective in blocking the novel coronavirus in laboratory experiments — a possible first step in the creation of a drug cocktail to battle COVID-19.
The antibody, known as STI-1499, performed well even though it was used at a concentration 10- to 100-fold lower than antibodies used to treat other diseases, the company said.
STI-1499 is one of more than a billion antibodies that Sorrento Therapeutics has been examining in an effort to find an effective treatment against a virus that has killed more than 85,000 people in the U.S.
By Gary Robbins and Jonathan Wosen | 15 May 2020
RELATED TOPICS:
Fresno State’s Randa Jarrar Dragged Out of Event Featuring Big Bang Theory’s Mayim Bialik
5 hours ago
Trump Calls Judge ‘Crooked’ After Facing a Warning of Jail Time if He Violates a Trial Gag Order
5 hours ago
Federal Reserve Says Interest Rates Will Stay at Two-Decade High Until Inflation Further Cools
5 hours ago
House Passes Bill Expanding Antisemitism Definition Amid Campus Protests Over Gaza War
5 hours ago
Trump Awarded 36 Million More Trump Media Shares Worth $1.8 Billion
7 hours ago
New Battlegrounds Emerge in California’s Political Guerrilla War Over Housing
8 hours ago
Fresno State Shows the Nation How a Peaceful Palestinian Protest is Done